Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if once-daily treatment with colchicine, compared to placebo, is effective in preventing gout flares in patients who are initiating therapy with allopurinol.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01451645
Study type Interventional
Source Regeneron Pharmaceuticals
Contact
Status Completed
Phase Phase 4
Start date October 2011
Completion date September 2012

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05522504 - Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
Completed NCT00829829 - PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1 Phase 3